Why the study?
What are the 30-day clinical outcomes and procedural success rates of transcatheter aortic valve implantation using the Edwards SAPIEN valve in a real-world European registry?
What are the 30-day clinical outcomes and procedural success rates of transcatheter aortic valve implantation using the Edwards SAPIEN valve in a real-world European registry?
The SOURCE registry demonstrates high procedural success and acceptable 30-day mortality for TAVI using the Edwards SAPIEN valve in high-risk patients in a real-world European setting.
No takes yet. Share an insight, caveat, or question.
Supports TAVI feasibility in high-risk patients; extends trial data to real-world European registries but leaves comparative effectiveness open.
Thomas et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: